0.0026
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eastgate Biotech Corporation (CE) | ETBI | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.0026 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0026 | 0.0026 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.00001 - 0.0048 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0026 | USD |
Period:
Draw Mode:
Eastgate Biotech Corporation (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.75M | 1.06B | - | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 92.50k | $ - | - | - | - |
Eastgate Biotech (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETBI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0026 | 0.0026 | 0.0026 | 0.0026 | 50,000 | 0.00 | 0.0% |
| 1 Month | 0.0026 | 0.0027 | 0.0026 | 0.0026229 | 32,750 | 0.00 | 0.0% |
| 3 Months | 0.0026 | 0.0027 | 0.0026 | 0.0026139 | 27,063 | 0.00 | 0.0% |
| 6 Months | 0.0027 | 0.0027 | 0.001 | 0.0024989 | 20,192 | -0.0001 | -3.7% |
| 1 Year | 0.0039 | 0.0048 | 0.00001 | 0.0013136 | 129,877 | -0.0013 | -33.33% |
| 3 Years | 0.006095 | 0.03 | 0.00001 | 0.0085544 | 465,859 | -0.0035 | -57.34% |
| 5 Years | 0.0089 | 0.03 | 0.00001 | 0.0036801 | 2,494,187 | -0.0063 | -70.79% |
Eastgate Biotech (CE) Description
| EastGate Biotech Corp. is a biotech company concentrating on altering the delivery ways for well-known drugs, currently administered only by injections, to non-invasive (oral or sublingual) routes. We are developing a technology platform for enhanced drug delivery designed to improve compliance and increase health benefits to fit todays health-conscious lifestyles. At the present time our technology focuses on the delivery of insulin via a liquid insulin mouth solution based on a proprietary/Trade Secret composition for the treatment of Type 2 diabetes patients and Alzheimers disease. We believe that our technology may also be applicable to the delivery of other active pharmaceutical ingredients. We may also develop other novel formulations of pharmaceutical and natural products. The company has identified several biologically active existing molecules that address unmet needs of patients, especially those with ever-growing chronic conditions. |